Biokuro verslo konsultacijos - Company finances
|
EUR
|
2019
From: 2019-02-21
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 44,735 | 44,975 | 25,935 | 39,000 | - | 9,800 | 6,000 |
| Profit before tax | 37,580 | 20,153 | 9,641 | 34,854 | 314 | 8,319 | 4,738 |
| Net profit | 37,580 | 19,145 | 9,159 | 33,111 | 245 | 7,902 | 4,454 |
| Equity | 7,580 | 16,725 | 15,884 | 48,996 | 49,240 | 57,195 | 61,649 |
| Liabilities | - | - | - | 15,643 | 69 | 417 | 884 |
| Non-current assets | 0 | 0 | 0 | 0 | 6,355 | 5,772 | 5,190 |
| Current assets | 37,594 | 27,732 | 36,366 | 64,639 | 42,954 | 51,840 | 57,343 |
| Total assets | 37,594 | 27,732 | 36,366 | 64,639 | 49,309 | 57,612 | 62,533 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 3,254 | 16 | 417 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | +0.5% | -42.3% | +50.4% | - | - | -38.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 100.0% | 69.0% | 25.2% | 51.2% | 0.5% | 13.7% | 7.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 495.8% | 114.5% | 57.7% | 67.6% | 0.5% | 13.8% | 7.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 84.0% | 42.6% | 35.3% | 84.9% | - | 80.6% | 74.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 84.0% | 44.8% | 37.2% | 89.4% | - | 84.9% | 79.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 0.3 | 0.0 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Biokuro verslo konsultacijos - Social security debts
The company had no debts to Sodra
Biokuro verslo konsultacijos - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Biokuro verslo konsultacijos, MB (code 305038627) is a small partnership engaged in business and other management consultancy activities. In 2025, the company generated €6.0K in revenue and €4.5K net profit, with a profit margin of 74.2%. Revenue declined by 38.8% year on year from €9.8K in 2024, while net profit also eased from €7.9K to €4.5K. Despite the lower turnover, profitability remained strong. Total assets increased to €62.5K in 2025 from €57.6K a year earlier, driven mainly by €57.3K of short-term assets, while long-term assets stood at €5.2K. Equity rose to €61.6K and liabilities stayed low at €884, leaving an equity ratio of 98.6% and a debt-to-equity ratio of 0.01. Return on equity was 7.2%, return on assets 7.1%, and asset turnover 0.10x. Over the 2023–2025 period, net profit increased from €245 in 2023 to €7.9K in 2024 before settling at €4.5K in 2025, alongside a steady expansion in equity and assets.